financetom
Business
financetom
/
Business
/
Martin Midstream says Glass Lewis backs buyout deal with Martin Resource
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Martin Midstream says Glass Lewis backs buyout deal with Martin Resource
Dec 18, 2024 11:30 AM

Dec 18 (Reuters) - Martin Midstream Partners ( MMLP )

said on Wednesday that proxy advisory firm Glass Lewis has

recommended the energy infrastructure firm's unitholders to vote

for the company's proposed buyout deal with Martin Resource

Management Corp.

The announcement of the Glass Lewis report comes days after

Martin Midstream ( MMLP ) had said that another proxy advisory firm

Institutional Shareholder Services (ISS) had also recommended a

positive vote for the deal.

However, two hedge funds Nut Tree Capital Management and

Caspian Capital, holding 13.6% of Martin Midstream ( MMLP ), are

promoting a rival bid and urging shareholders to vote against

the deal.

The two hedge funds have argued that a $4.02 per common unit

deal undervalues the company.

The unitholder meet is scheduled for Dec. 30.

Martin Midstream ( MMLP ) agreed to a $157 million deal with Martin

Resource in October.

Martin Midstream ( MMLP ), which focuses on storing and transporting

fuels, said Glass Lewis has reported the merger represents an

"attractive exit valuation and premium for the company's

unaffiliated unitholders".

Nut Tree, Caspian, Glass Lewis and ISS did not immediately

respond to requests for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen Completes Acquisition of Alcyone Therapeutics
Biogen Completes Acquisition of Alcyone Therapeutics
Nov 14, 2025
04:24 PM EST, 11/14/2025 (MT Newswires) -- Biogen (BIIB) on Friday said it completed its acquisition of Alcyone Therapeutics, adding the company's ThecaFlex DRx implantable intrathecal delivery system to support future use with Spinraza, its spinal muscular atrophy treatment. The device is designed to replace repeat lumbar punctures and is currently being studied in the PIERRE trials. Biogen said it...
Ensysce Biosciences reports Q3 net loss
Ensysce Biosciences reports Q3 net loss
Nov 14, 2025
Overview * Ensysce reports Q3 net loss of $3.7 mln, driven by increased R&D expenses * Company initiates Phase 3 study of PF614, marking a major milestone * Ensysce completes $4 mln preferred stock financing to support development Result Drivers * Cash and cash equivalents were $1.7 million as of September 30, 2025, compared to $3.5 million as of December...
NXP Semiconductors Insider Sold Shares Worth $1,473,887, According to a Recent SEC Filing
NXP Semiconductors Insider Sold Shares Worth $1,473,887, According to a Recent SEC Filing
Nov 14, 2025
04:21 PM EST, 11/14/2025 (MT Newswires) -- William Betz, Executive Vice President & CFO, on November 13, 2025, sold 7,299 shares in NXP Semiconductors ( NXPI ) for $1,473,887. Following the Form 4 filing with the SEC, Betz has control over a total of 1,885 common shares of the company, with 1,520 shares held directly and 365 controlled indirectly. SEC...
Venu Holding Q3 Loss Widens, Revenue Falls
Venu Holding Q3 Loss Widens, Revenue Falls
Nov 14, 2025
04:25 PM EST, 11/14/2025 (MT Newswires) -- Venu Holding ( VENU ) reported a Q3 loss of $0.15 per diluted share, widening from a loss of $0.13 a year earlier. Two analysts polled by FactSet expected a loss of $0.25. Revenue for the three months ended Sept. 30 was $5.4 million, down from $5.5 million a year earlier. Two analysts...
Copyright 2023-2026 - www.financetom.com All Rights Reserved